Javier Santoyo

@jsantoyo.bsky.social did:plc:oij6dmtiwwevddoiyroctsds

Genomics & Bioinformatics #Omics #NGS #LongReads 🧪🧬 🖥️ Opinions my own. He/Him LinkedIn: https://www.linkedin.com/in/javiersantoyolopez/

No Bluesky desde 6 novembro 2023

Resumo

Javier Santoyo (@jsantoyo.bsky.social) é um usuário do Bluesky desde 6 novembro 2023. Tem 2.311 seguidores, segue 1.985 contas e publicou 970 posts.

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Curtidas públicas da rede Bluesky.

Zamin Iqbal@zaminiqbal.bsky.social04/03/2026 22:49
Postdoc on AI/biology funded by asanger and DeepMind! www.sanger.ac.uk/news_item/ne...
Ver post
bioRxivpreprint@biorxivpreprint.bsky.social04/03/2026 22:48
Towards Useful and Private Synthetic Omics: Community Benchmarking of Generative Models for Transcriptomics Data https://www.biorxiv.org/content/10.64898/2026.03.02.707794v1
Ver post
Shawn Baker@sandiegomics.bsky.social19/02/2026 17:50
Element reveals more information about their VITARI platform, a foray into the high-throughput sequencing market. sandiegomics.com/element-join...
Ver post
SCIENMAG@scienmag.bsky.social13/10/2025 14:32
Unlocking mRNA Markers via QNome Nanopore Sequencing In a groundbreaking development poised to revolutionize forensic science and personalized medicine, researchers have unveiled the immense potential of messenger RNA (mRNA) markers in body fluids, harnessed through an advanced sequencing…
Ver post
Adam Ameur@adameur.bsky.social13/10/2025 14:31
New preprint for sequencing enthusiasts!🧬💻 We benchmarked Element Biosciences’ AVITI against Illumina NovaSeq, with validation using PacBio Revio. All platforms are available at NGI Sweden! Great work led by Pontus Höijer and Robert Månsson. www.biorxiv.org/content/10.1...
Ver post

No Bluesky, bloqueios são registros públicos.

Esta conta não bloqueia ninguém.